PEPPOLONI, Samuele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.911
NA - Nord America 12.166
AS - Asia 5.954
SA - Sud America 660
AF - Africa 86
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
Totale 39.804
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.378
US - Stati Uniti d'America 11.987
SG - Singapore 2.299
GB - Regno Unito 2.168
CN - Cina 1.841
HK - Hong Kong 811
DE - Germania 713
SE - Svezia 651
FR - Francia 570
BR - Brasile 535
UA - Ucraina 331
RU - Federazione Russa 265
VN - Vietnam 249
TR - Turchia 224
FI - Finlandia 204
KR - Corea 134
BG - Bulgaria 120
MX - Messico 100
IN - India 93
NL - Olanda 81
AT - Austria 79
ID - Indonesia 63
AR - Argentina 61
PL - Polonia 53
CA - Canada 51
RO - Romania 47
BE - Belgio 46
JP - Giappone 39
IE - Irlanda 36
ZA - Sudafrica 36
BD - Bangladesh 35
CH - Svizzera 32
IQ - Iraq 30
ES - Italia 28
LT - Lituania 18
MA - Marocco 18
PT - Portogallo 18
IR - Iran 17
MY - Malesia 17
CZ - Repubblica Ceca 16
AE - Emirati Arabi Uniti 14
AU - Australia 14
EC - Ecuador 12
CO - Colombia 11
DK - Danimarca 10
TH - Thailandia 10
UZ - Uzbekistan 10
VE - Venezuela 10
IL - Israele 9
TW - Taiwan 9
CL - Cile 8
PK - Pakistan 8
PY - Paraguay 8
EU - Europa 7
HN - Honduras 7
KE - Kenya 7
PE - Perù 7
AL - Albania 6
JO - Giordania 6
NO - Norvegia 6
UY - Uruguay 6
EG - Egitto 5
KG - Kirghizistan 5
PA - Panama 5
AM - Armenia 4
CR - Costa Rica 4
DZ - Algeria 4
MT - Malta 4
NP - Nepal 4
PH - Filippine 4
RS - Serbia 4
SM - San Marino 4
SN - Senegal 4
TN - Tunisia 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HR - Croazia 3
LV - Lettonia 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AN - Antille olandesi 2
BH - Bahrain 2
CG - Congo 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
MD - Moldavia 2
MG - Madagascar 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
Totale 39.787
Salva come PNG Salva come JPEG
Città #
Singapore 1.686
Southend 1.564
Santa Clara 1.384
Ashburn 918
Fairfield 855
Hong Kong 810
Chandler 781
Woodbridge 644
Hefei 631
Milan 626
Jacksonville 600
Rome 589
Houston 511
Bologna 450
Dearborn 446
Ann Arbor 444
Wilmington 347
Nyköping 335
Seattle 317
Beijing 307
Torino 290
London 276
Chicago 272
Los Angeles 255
Cambridge 229
Florence 227
Modena 227
New York 168
Catania 146
Seoul 127
Genova 125
Council Bluffs 118
Padova 118
Princeton 118
Verona 117
Sofia 116
Izmir 114
Dallas 108
Salt Lake City 108
Castelnuovo Rangone 105
Bremen 103
Eugene 102
Venezia 101
Moscow 98
Napoli 94
The Dalles 93
Des Moines 92
San Diego 92
Turin 92
Helsinki 90
Munich 88
Ho Chi Minh City 86
Pisa 81
Shanghai 81
Palermo 77
Reggio Nell'emilia 77
Redwood City 76
Nuremberg 74
Bari 71
Mexico City 68
Trento 66
Naples 65
Buffalo 63
Elk Grove Village 58
Tampa 58
Trieste 56
São Paulo 54
Hanoi 52
Bolzano 50
Parma 50
Piemonte 50
Boardman 48
Falls Church 47
Jakarta 47
Udine 46
Oggiono 45
Monza 44
Vienna 43
Norwalk 41
Genoa 40
Messina 39
Tokyo 36
Nanjing 35
Pavia 35
San Jose 34
Brussels 33
Dublin 33
Rio Saliceto 33
Cagliari 32
Columbus 32
Mountain View 32
Stockholm 31
Atlanta 30
Frankfurt am Main 30
Reggio Emilia 30
Kent 28
Prato 28
Dolo 27
Warsaw 27
Guangzhou 26
Totale 20.999
Salva come PNG Salva come JPEG
Nome #
RICERCA DI MARCATORI PER LA DIAGNOSI DI INFEZIONE FUNGINA INVASIVAE (IFI) MEDIANTE APPROCCIO DIAGNOSTICO COMBINATO 15.205
Yessotoxin inhibits phagocytic activity of macrophages. 417
Ruolo della proteina pneumococcica di superficie PspC nel l’interazione in vitro di Streptococcus pneumoniae con le cellule microgliali 409
The encapsulated strain TIGR4 of Streptococcus pneumoniae is phagocytosed but is resistant to intracellular killing by mouse microglia 395
Adaptive response of microglial cells to in vitro infection by Candida albicans isolates with different genomic backgrounds 390
A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections 379
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 363
EFFETTI DELLA TOSSINA DI ORIGINE ALGALE YESSOTOSSINA (YTX) SULLA ATTIVITA’ DEL MACROFAGO 359
Genomic and phenotypic variation in morphogenetic networks of two Candida albicans isolates subtends their different pathogenic potential 355
RUOLO BIOLOGICO DI DUE RECETTORI TOLL-SIMILI, TLR2 E TLR4, NELLA RISPOSTA MACROFAGICA A CANDIDA ALBICANS 347
Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome λ-display library 336
Longitudinal Survey of Fungi in the Human Gut: ITS Profiling, Phenotyping, and Colonization 331
NF-kB activation and p38 phosphorilation in microglial cells infected with Leptospira or exposed to partially purified leptospiral lipoproteins 326
La proteina di superficie PspC di pneumococco conferisce resistenza al killing in vitro di Streptococcus pneumoniae da parte di cellule microgliali in maniera indipendente dal complemento 326
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 325
Detection of follicular fluid and serum antibodies by protein microarrays in women undergoing in vitro fertilization treatment. 324
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 312
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 311
An antibody reactivity-based assay for diagnosis of invasive candidiasis using protein array 296
A synthetic killer peptide impairs Candida albicans biofilm formation and persistence in vitro 294
ALTERATA REATTIVITA’ MACROFAGICA IN CORSO DI INFEZIONE MISTA DA VIRUS E FUNGHI:VALUTAZIONI FUNZIONALI, CITOFLUORIMETRICHE E DI ESPRESSIONE GENICA 286
Role of the (Mn)superoxide dismutase of Enterococcus faecalis in the in vitro interaction with microglia 281
Contribution of different pneumococcal virulence factors to experimental meningitis in mice 277
Acellular pertussis vaccines composed of genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults. 271
Safety and immunogencity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study 270
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 270
The lack of Pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglial cells 266
Antimicrobial and antibiofilm efficacy of a copper/calcium hydroxide-based endodontic paste against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans 266
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old children. 264
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 264
Effects of Cupral® on the formation and persistence of microbial biofilms in vitro 257
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences 255
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 251
The quest for a vaccine against Helicobacter pylori: how to move from mouse to man? 246
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 246
RUOLO DELLA SUPEROSSIDO DISMUTASI DI Enterococcus faecalis SULLA REATTIVITA’ DELLA MICROGLIA IN VITRO 245
CANDIDA ALBICANS HYPHAL DEVELOPMENT AND BIOFILM FORMATION/PERSISTENCE ARE DIFFERENTIALLY AFFECTED BY MOUTHWASHES DEPENDING UPON THEIR COMPOSITION. 240
Antibody-dependent macrophage-mediated activity against Helicobacter pylori in the absence of complement 238
Immunogenicity of the B monomer of Escherichia coli heat-Labile Toxin expressed on the surface of the Streptococcus gordonii 234
New strategies for the prevention and treatment of Helicobacter pylori infection 231
The Spr1875 protein confers resistance to the microglia-mediated killing of Streptococcus pneumoniae 230
Candida albicans survival, growth and biofilm formation are differently affected by mouthwashes: an in vitro study 230
Diagnostic utility of a microarray based on 11 proteins of Candida albicans for the diagnosis of invasive candidiasis 229
Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. 228
The TIGR4 strain of Streptococcus pneumoniae is phagocytosed but resists intracellular killing by microglia in experimental pneumococcal meningitis 227
Immunogenic Properties of Streptococcus agalactiae FbsA Fragments 222
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 220
Mutants of Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines. 219
Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity 219
Immunostimulation by a partially retro-inverso tuftsin analogue containing Thr 1 (NHCO) (R,S) Lys 2 modification 218
The Pneumococcal surface protein C (PspC) influences the susceptibility of Streptococcus pneumoniae to microglia 217
Safety and immunogenicity in animals of subunit influenza vaccine given intranasally with mutants of Escherichia coli heat-labile enterotoxin (LT) 217
Metabolic, humoral and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G 215
COMPARAZIONE DELLA EFFICACIA ANTIBATTERICA DI TETRACLEAN, UN IRRIGANTE ENDODONTICO DI NUOVA GENERAZIONE, CON IPOCLORITO DI SODIO. 214
Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: Safety, immunogenicity, and efficacy 209
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 response following nasal delivery 208
Applicazioni del microarray proteico nella diagnosi diretta per la sierotipizzazione di agenti patogeni 207
Caratterizzazione immunobiologica di nuovi antigeni proteici di Streptococcus pneumoniae selezionati mediante "phage display" 206
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin 206
APPLICAZIONE DEI MICROARRAY PROTEICI NELLA DIAGNOSTICA AVANZATA DI PATOLOGIEMICROBICHE E VIRALI 205
Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans 205
Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform 204
The ABC transporter-encoding gene AFR1 affects the resistance of Cryptococcus neoformans to microglia-mediated antifungal activity by delaying phagosomal maturation. 203
Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine 199
Host-microbe interaction in Candida mucosal infections: a complex balance (Interazione ospite-microrganismo nelle infezioni mucosali da Candida: un equilibrio complesso) 197
MICROARRAY PROTEICI NELLA DIAGNOSI DIRETTA: SIEROTIPIZZAZIONE DI AGENTI PATOGENI 194
Lymphokine secretion and cytotoxic activity of human CD4+ T cell clones against Bordetella pertussis 193
Physicochemical characterisation of the pertussis vaccine. 193
The protein “mycoarray”: a novel serological assay for the laboratory diagnosis of primitive endemic mycoses 193
Alterazione delle difese monocito-mediate nei confronti di miceti in presenza di virus erpetici 191
Immunobiological characterization of genetic products, identified from whole genome lambda-display libraries of Pneumococcus 189
Alterazione delle difese monocito-mediate nei confronti di Cryptococcus neoformans in presenza dell’Herpesvirus umano 6 189
In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets. 188
Attenuation of Pseudomonas aeruginosa Virulence by Pomegranate Peel Extract 187
IL MICROARRAY PROTEICO NELL’ANALISI DEI LIQUIDI AMNIOTICI: RICERCA DI MARKER PRECOCI DI INFIAMMAZIONE E/O INFEZIONE CORRELABILI AL PARTO PRETERMINE 184
Pneumocystis jirovecii genotyping: experience in a tertiary-care hospital in Northern Italy 184
Probing the structure-activity relationship of E.coli LT-A by site directed mutagenesis 183
The Spr1875 protein of Streptococcus pneumoniae protects the bacterium from microglia-mediated killing 183
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 183
Interaction of pneumococcal surface structures with microglia 177
Protein microarrays on midtrimester amniotic fluids: a novel approach for the diagnosis of early intrauterine inflammation related to preterm delivery 173
Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis 173
Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizaztion 170
RUOLO DI PRODOTTI GENICI IDENTIFICATI MEDIANTE LIBRERIE LAMBDA-DISPLAY DA GENOMA COMPLETO DI PNEUMOCOCCO NELL’INTERAZIONE IN VITRO CON CELLULE MICROGLIALI ED EPITELIALI 169
Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm development. 169
Bordetella 168
Risposta differenziale della cellula di microglia ad isolati clinici di Candida albicans con differente genotipo 165
LA PROTEINA SPR1875 DI STREPTOCOCCUS PNEUMONIAE PROTEGGE IL BATTERIO DAL KILLING DELLA MICROGLIA 165
Properties of the pertussis toxin mutant PT-9K/129G after formaldehyde treatment. 164
Il gene AFR1 di Cryptococcus neoformans codificante per un trasportatore ABC, altera la resistenza del patogeno alla microglia: ritardo nella maturazione dei fagosomi. 163
Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with FHA and pertactin in infants and children 156
A short synthetic peptide fragment of human interleukin-1 beta increases both human and murine natural killer activity 156
Brucella 151
Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells 151
Ruolo del sierotipo capsulare nella suscettibilità di Streptococcus pneumoniae alla cellula microgliale 149
Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 K 147
The polisaccharyde capsule is necessary for the development of fatal pneumococcal meningitis in mice 143
Pomegranate extract affects fungal biofilm production: consumption of phenolic compounds and alteration of fungal autoinducers release 138
EDTA and Taurolidine affect Pseudomonas aeruginosa virulence in vitro: impairment of secretory profile and biofilm production onto peritoneal dialysis catheters 138
Haemophilus 134
Totale 38.265
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.666
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.170 0 0 0 0 0 417 271 333 214 390 301 244
2021/20222.991 187 281 219 250 168 192 194 209 273 206 437 375
2022/20234.240 398 344 313 375 465 519 210 412 470 152 257 325
2023/20242.432 220 236 218 204 364 203 222 207 96 112 130 220
2024/20255.361 228 167 110 360 1.049 735 404 362 561 203 527 655
2025/20266.061 620 472 686 1.584 2.161 538 0 0 0 0 0 0
Totale 40.180